Wall Street is positive on Sorrento Therapeutics Inc (SRNE). On average, analysts give SRNE a Strong Buy rating. The average price target is $26.666, which means analysts expect the stock to gain by 514.42% over the next twelve months.
That average ranking earns SRNE an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating SRNE a Strong Buy today. Find out what this means to you and get the rest of the rankings on SRNE!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Sorrento Therapeutics Inc Stock Today?
Sorrento Therapeutics Inc (SRNE) stock is trading at $4.34 as of 2:26 PM on Thursday, Jan 20, a gain of $0.03, or 0.79% from the previous closing price of $4.31. The stock has traded between $4.29 and $4.53 so far today. Volume today is light. So far 3,754,957 shares have traded compared to average volume of 5,845,687 shares.
Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
